Healthcare Analytics in the Second Half of 2026: The Five Initiatives Worth Prioritizing

Mid-year is when smart analytics teams reset. Q1 priorities turn out to be partly right, partly wrong, and partly outpaced by changes nobody predicted. Five initiatives are worth prioritizing for the second half of 2026 — and three things are worth deprioritizing without guilt.

Priority 1: Connector implementation, where it's still on the to-do list

Most teams that planned to stand up a direct EHR connector in 2026 haven't. The reasons are familiar — IT cycles, security review, vendor selection. But the second-half opportunity cost of not having a live connector is real: every Q3 question that requires fresh data takes 2-3 days instead of seconds. See connector list and how to get IT to approve it.

Priority 2: Mid-year MIPS / quality intervention

Q3 is the last useful intervention window for measure improvement that affects the current year. Practices using mid-year analytics views typically gain 4-6 points by year-end. See mid-year MIPS performance.

Priority 3: Q4 RCM cleanup

Year-end revenue cycle review surfaces denials, AR drift, and charge capture gaps with enough lead time to recover. The same analytics is much less effective in Q1 of the following year because documentation has cooled.

Priority 4: Cost-category intervention for MIPS

High-MSPB outliers identified in July can still be moved to care management for impact this calendar year. After September the time-to-impact is too short.

Priority 5: 2027 planning prep

Budget cycles for 2027 typically start in Q3. Analytics priorities for 2027 should reflect what 2026 actually taught — connector breadth, conversational interfaces, value-based contract analytics, AI governance.

What to deprioritize

• New dashboard projects without a clear business question. Dashboards built without a specific user and question default to “built and ignored.” If the project doesn't name the user and the decision the dashboard supports, defer it.
• Custom-built measure logic that duplicates vendor-shipped logic. If your analytics platform ships HEDIS or NQF measure libraries, building parallel custom versions creates audit risk without benefit.
• Multi-year analytics platform commitments without flexibility. Analytics architecture is changing too fast in 2026 to lock into 3-5 year deals. Flat monthly with cancel rights is the right structure for most healthcare buyers right now.

The H2 2026 north star

The single best-leveraged use of H2 2026 analytics time: closing the loop between insight and action. Every additional analytics view that doesn't connect to a workflow change is overhead. Every view that does is value. The teams that internalize that distinction outperform.